Literature DB >> 17194571

Relative efficacy of psychotherapy and combined therapy in the treatment of depression: a meta-analysis.

Saskia M de Maat1, Jack Dekker, Robert A Schoevers, Frans de Jonghe.   

Abstract

BACKGROUND: Reviews of the relative efficacy of psychotherapy and combined therapy (psychotherapy with pharmacotherapy) for depression have yielded contradicting conclusions. This may be explained by the clinical heterogeneity of the studies reviewed. AIMS: To conduct a meta-analysis with an acceptable level of homogeneity in order to investigate the relative efficacy of psychotherapy and combined therapy in the acute treatment of depression.
METHOD: A systematic search was performed for RCTs published between 1980 and 2005 comparing psychotherapy and combined therapy in adult psychiatric outpatients with non-psychotic unipolar major depressive disorder. The studies were classified according to the chronicity and severity of the depression. Data were pooled by means of meta-analysis and statistical tests were conducted to measure heterogeneity.
RESULTS: The meta-analysis included seven studies looking at a total of 903 patients. None of the heterogeneity tests established significance. This indicates a lack of evidence for the heterogeneity of the results. The dropout rates did not differ significantly between the two treatment modalities (25% in combined therapy and 24% in psychotherapy, p=0.77). At treatment termination, the intention-to-treat remission rate for combined therapy (46%) was better than for psychotherapy (34%) (p=0.0007); Relative Risk 1.32 (95% CI: 1.12-1.56), Odds Ratio 1.59 (95% CI: 1.22-2.09). In moderate depression, the difference between the remission rate for combined therapy and psychotherapy was statistically significant (47% compared to 34% respectively, p=0.001). This was not the case in mild major depression (42% compared to 37% respectively, p=0.29). The difference was also statistically significant in chronic major depression (48% compared to 32%, p<0.001), but not in non-chronic major depression (43% compared to 37%, p=0.22). On a more specific level, no differences were found in the remission rates for the treatment modalities in mild or moderate non-chronic depression. Combined therapy led to significantly better results than psychotherapy in moderate chronic depression only (48% compared to 32%, p<0.001).
CONCLUSIONS: In the acute treatment of adult psychiatric outpatients with major depressive disorder, patient compliance with combined therapy matches compliance with psychotherapy alone. Combined therapy is more efficacious than psychotherapy alone. However, these results depend on severity and chronicity. Combined therapy outperformed psychotherapy in moderate chronic depression only. No differences were found in mild and moderate non-chronic depression. No data were found for mild chronic depression and for severe depression.

Entities:  

Mesh:

Year:  2006        PMID: 17194571     DOI: 10.1016/j.eurpsy.2006.10.008

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  39 in total

1.  Maternal Depression and Early Intervention: A Call for an Integration of Services.

Authors:  Shanna L Alvarez; Samantha Meltzer-Brody; Marcia Mandel; Linda Beeber
Journal:  Infants Young Child       Date:  2015 Jan-Mar

2.  Enhanced depression care for patients with acute coronary syndrome and persistent depressive symptoms: coronary psychosocial evaluation studies randomized controlled trial.

Authors:  Karina W Davidson; Nina Rieckmann; Lynn Clemow; Joseph E Schwartz; Daichi Shimbo; Vivian Medina; Gabrielle Albanese; Ian Kronish; Mark Hegel; Matthew M Burg
Journal:  Arch Intern Med       Date:  2010-04-12

Review 3.  Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 2. Psychological Treatments.

Authors:  Sagar V Parikh; Lena C Quilty; Paula Ravitz; Michael Rosenbluth; Barbara Pavlova; Sophie Grigoriadis; Vytas Velyvis; Sidney H Kennedy; Raymond W Lam; Glenda M MacQueen; Roumen V Milev; Arun V Ravindran; Rudolf Uher
Journal:  Can J Psychiatry       Date:  2016-08-02       Impact factor: 4.356

4.  Symptom-Specific Effects of Psychotherapy versus Combined Therapy in the Treatment of Mild to Moderate Depression: A Network Approach.

Authors:  Ella Bekhuis; Robert Schoevers; Marrit de Boer; Jaap Peen; Jack Dekker; Henricus Van; Lynn Boschloo
Journal:  Psychother Psychosom       Date:  2018-03-01       Impact factor: 17.659

Review 5.  Finding intestinal fortitude: Integrating the microbiome into a holistic view of depression mechanisms, treatment, and resilience.

Authors:  M C Flux; Christopher A Lowry
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

Review 6.  Treatment of Depression in Primary Care with Computerized Psychological Therapies: Systematic Reviews.

Authors:  Francisco Rodriguez-Pulido; Gema Castillo; Sofiane Hamrioui; Laura Delgado Martin; Pilar Vazquez-Beltrán; Isabel de la Torre-Díez; Manuel A Franco-Martín
Journal:  J Med Syst       Date:  2020-02-13       Impact factor: 4.460

7.  The prevalence and predictors of mental health treatment services in a national sample of depressed veterans.

Authors:  Stephen T Chermack; Kara Zivin; Marcia Valenstein; Mark Ilgen; Karen L Austin; John Wryobeck; Frederic C Blow
Journal:  Med Care       Date:  2008-08       Impact factor: 2.983

Review 8.  Chronic depression: update on classification and treatment.

Authors:  Dana C Torpey; Daniel N Klein
Journal:  Curr Psychiatry Rep       Date:  2008-12       Impact factor: 5.285

Review 9.  [Affective disorders. The significance of psychotherapeutic approaches].

Authors:  M Berger; E L Brakemeier; C Klesse; E Schramm
Journal:  Nervenarzt       Date:  2009-05       Impact factor: 1.214

Review 10.  Managing the patient with co-morbid depression and an anxiety disorder.

Authors:  Robert A Schoevers; Henricus L Van; Vincent Koppelmans; Simone Kool; Jack J Dekker
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.